There's no ignoring it. President Trump's tariffs and trade threats are roiling the markets, sending the S&P 500 into a correction for the first time since 2022. The tariffs announced today were just the latest move fueling investor uncertainty.Meanwhile, consumer sentiment is rapidly falling, and businesses are increasingly fearful as the manufacturing sector just fell into a contraction, according to the March ISM survey. Much of the economy is at risk from tariffs and the impact of a weakening economy. F ...

Group 1: Market Overview - The end of Q1 2025 is approaching, with many S&P 500 stocks showing strong year-to-date performances despite recent volatility from tariff discussions and economic developments [1] - Notable top performers include Philip Morris (PM), CVS Health (CVS), and Newmont (NEM) [1] Group 2: Philip Morris (PM) - Philip Morris has reported better-than-expected results, with EPS growing by 14% and sales increasing by 7% [2] - Smoke-free products exceeded 40 billion units for the first time in FY24, with net revenues for the Smoke-free Business (SFB) rising by 14.2% and gross profit increasing by 18.7% [3] - The company offers a high dividend yield of 3.5% annually and is recognized as a Dividend King [3] Group 3: CVS Health (CVS) - CVS shares have rebounded significantly in 2025, up 50% year-to-date, ending a prolonged decline [5] - The company experienced a 4% year-over-year sales increase, although EPS declined by 44% [5] - Analysts are optimistic about upcoming quarterly results, with a consensus EPS estimate of $1.62 per share, reflecting a 12% increase and 23% year-over-year growth [7] Group 4: Newmont (NEM) - Newmont, a major gold producer, has seen its stock rise nearly 30% year-to-date, driven by a surge in gold prices [8] - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year [9] - The company reported a record free cash flow of $1.6 billion, enhancing its ability to pay dividends and reduce debt [9][13]

Investing in "sin stocks" — shares of companies engaged in industries deemed unethical or immoral by some — has long been a subject of debate. These include companies operating in industries considered unethical or controversial, such as alcohol, tobacco and gambling. Despite the moral concerns, sin stocks have historically outperformed broader markets and offered attractive returns due to their strong cash flows, loyal customer bases and inelastic demand. While ethical investing has gained traction, many i ...

Perhaps not surprisingly, defensive stock Philip Morris International ( PM ) has been one of the best-performing US companies this year. When I initially covered the stock in November 2024, I argued that it was a best-in-class defensive stock with strongI am an investment professional with a background in both equity and real estate markets. I specialize in identifying long-only opportunities that offer safe and growing dividends, aiming to outperform the broader market on a risk-adjusted return basis. In a ...

Core Insights - Philip Morris International (NYSE: PM) has experienced a significant increase of 66% over the past year, outperforming NVIDIA's (NVDA) 12-month returns amidst a broader market trend [1]. Company Performance - The stock performance of Philip Morris International has been notably strong, with a 66% rise in value over the last year, indicating robust investor interest and confidence in the company's future prospects [1]. Market Context - The current market environment shows a shift in investor focus, with analysts primarily concentrating on AI technologies, yet Philip Morris is achieving substantial returns that surpass those of major tech companies like NVIDIA [1].

Core Viewpoint - The article compares Altria and Philip Morris International, highlighting their differing business models, financial performance, and growth prospects in the tobacco industry, particularly in the context of their transitions to smoke-free products. Business Model Comparison - Altria and Philip Morris, despite sharing cigarette brands, have different business models, with Altria focusing on the U.S. market and Philip Morris on international markets [2][3] - Philip Morris has successfully developed next-generation products like Iqos and Zyn, gaining significant market share, while Altria has struggled with its investments in Juul and cannabis [4][5][6] Financial Performance - In 2024, Altria's revenue declined by 1.9% to $24 billion, primarily due to a 10.2% drop in cigarette shipment volume, although it maintained a high adjusted operating margin of 61.2% [8][9] - Philip Morris reported a 7.7% increase in revenue to $37.9 billion, with a 0.6% rise in international cigarette volume and a 16% increase in operating income [9] Dividend and Valuation - Altria offers a dividend yield of 7% and trades at a price-to-earnings ratio of 11.3, maintaining a strong reputation as a dividend payer [10][11] - Philip Morris has a lower dividend yield of 3.5% but a higher P/E ratio of 22, reflecting its faster growth and success in next-gen products [11] Growth Prospects - Altria is beginning to see growth from its investment in Njoy, but it continues to face revenue losses and challenges in its core cigarette business [12] - Philip Morris is experiencing growth in both its next-gen products and its cigarette business, indicating a more favorable long-term growth trajectory [12][13]

Market Overview - The stock market began 2025 strong but has recently faced challenges due to trade wars and tariffs, with the S&P 500 down nearly 4.5% year to date [1] CVS Health - CVS Health has seen a significant increase of approximately 51% in 2025, boosted by better-than-expected year-end earnings and guidance in line with Wall Street expectations [3][4] - The company had a difficult previous year, with shares dropping by 43%, leading to a change in CEO, which has contributed to improved investor sentiment [4][5] - Despite the positive performance, CVS faces high medical costs and uncertainty in the healthcare sector, with a current valuation of 18 times trailing earnings, indicating it is not overly expensive [5][6] Super Micro Computer - Super Micro Computer's stock has risen by 26.5% in 2025, recovering from previous concerns about its financial statements and auditor issues [7][8] - The company successfully filed its financial statements on time with a new auditor, alleviating fears of delisting, and is benefiting from increased demand for IT infrastructure driven by AI developments [8] - However, the company reported a gross profit of $2.1 billion on sales of $14.9 billion, indicating thin margins, and potential risks from economic conditions and tariffs [9] Philip Morris International - Philip Morris International's shares increased by 27.9% in 2025, following better-than-expected guidance for adjusted earnings per share [10] - The stock received a boost from regulatory approval to market its nicotine pouch, Zyn, in the U.S., although concerns remain about the health implications of such products [11][12] - Despite the positive start to the year, the stock trades at 25 times earnings, raising questions about its long-term viability in a declining tobacco market [12]

Economic Outlook - The U.S. economy is showing signs of potential recession, with the Atlanta Federal Reserve predicting a 2.1% decline in Q1 GDP after earlier forecasts of over 2% growth [1] Walmart - Walmart is positioned as a top defensive stock, having gained 2% during the Covid recession while the S&P 500 lost 25%, and rose 12% during the Great Recession of 2008-2009 [2][3] - The company benefits from its size and scale, providing significant buying power that allows it to be a price leader during economic downturns [4] - Walmart's extensive reach means 90% of the U.S. population lives within 10 miles of a store, which supports its Walmart+ membership growth, particularly among wealthier consumers [5] - Upper-income households, defined as those earning $100,000 or more, have been a key growth driver for Walmart, potentially increasing their patronage during a recession [6] - Walmart is also expanding its advertising and online marketplace businesses, enhancing fulfillment capabilities for third-party merchants [7] Philip Morris International - Philip Morris International's traditional cigarette business remains strong, with modest volume growth and strong pricing power, particularly in international markets [8] - The company's smokeless products, such as Zyn and IQOS, are significant growth drivers, with Zyn projected to see volume growth of 34% to 41% this year [9] - IQOS has also experienced solid growth, with plans for broader rollout in the U.S. pending FDA approval [10] - Zyn and IQOS offer better unit economics compared to traditional cigarettes, with Zyn's contribution level being six times greater and IQOS's twice as good [11] - The addictive nature of Philip Morris' products makes them resilient during economic downturns, and the company offers a 3.5% dividend yield, making it an attractive growth stock in a defensive industry [12]

Core Insights - The article emphasizes the importance of conducting personal in-depth research and due diligence before making investment decisions [3]. Group 1 - The analysis is intended for informational purposes and should not be considered professional investment advice [3]. - There is a clear statement that past performance does not guarantee future results, highlighting the inherent uncertainties in investment [4]. - The article expresses that the views or opinions may not reflect those of the platform as a whole, indicating a diversity of perspectives among analysts [4].

Core Viewpoint - The market has reacted negatively to recent tariff news and economic data indicating a slowing consumer, yet companies like Coca-Cola, Philip Morris, and Johnson & Johnson have shown resilience and strength in their stock performance during this period [1][18]. Coca-Cola (KO) - Coca-Cola exceeded consensus EPS and sales expectations with growth rates of 12% and 6% respectively, and its gross margin has improved from early 2023 lows [4]. - The company gained market share in the nonalcoholic ready-to-drink beverage sector in North America, with an impressive 11% increase in overall price/mix during FY24 [7]. - Coca-Cola has a 4% five-year annualized dividend growth rate, reinforcing its status as a Dividend King [8]. Philip Morris (PM) - Philip Morris reported a 14% growth in EPS and a 7% increase in sales, with strong demand for its products and a focus on innovation [10]. - The company’s smoke-free products surpassed 40 billion units for the first time in FY24, with net revenues for its Smoke-free Business increasing by 14.2% [11]. - PM has a market-beating annual dividend yield of 3.5% and is expected to see an 8.9% year-over-year earnings growth in FY25 [12]. Johnson & Johnson (JNJ) - Johnson & Johnson shares have shown modest growth of 5% over the past three years, compared to the S&P 500's 46% gain, but the stock's stability is a key takeaway [13]. - The company is also a Dividend King, with a 3.0% annual yield and a 5.5% five-year annualized dividend growth rate [15]. - JNJ's strong cash-generating capabilities and consistent pipeline have positioned its shares favorably, leading to a positive post-earnings movement [17].